Paraneoplastic limbic encephalitis

被引:17
作者
Farrugia, ME
Conway, R
Simpson, DJ
Kurian, KM
机构
[1] Ninewells Hosp, Dept Neurol, Dundee DD1 9SY, Scotland
[2] Roxburghe House, Dept Palliat Med, Dundee, Scotland
[3] Western Gen Hosp, Neuropathol Lab, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
paraneoplastic; limbic encephalitis; occult malignancy; immune-mediated; palliative care; hospice;
D O I
10.1016/j.clineuro.2004.02.029
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Paraneoplastic limbic encephalitis (PLE) is a rare neurological consequence of a variety of cancers, most commonly originating from lung, breast and testis. The aetiology is believed to be immune-mediated, caused by tumour-induced autoimmunity launching an attack against one's own central nervous system. The patient may present with amnesia, depression, anxiety, seizures and/or personality changes. The onset of these symptoms may precede the diagnosis of malignancy by a period of up to 2 years. The malignancy may be occult and unless the syndrome is recognised, it may fail to be detected. The diagnosis of PLE is suggested by the clinical picture, MRI evidence of mesial temporal lobe abnormality and CSF abnormalities such as the presence of oligoclonal bands. It may be further supported by the presence of paraneoplastic antibodies in the serum. Immunosuppression has been tried in some cases but memory impairment is often irreversible. There are several case reports in the literature of paraneoplastic limbic encephalitis but few emphasise, the resulting impact that this may have on the patient's quality of life and their carers. The accompanying amnesia is often far more distressing to the caters, who are aware of the limitations of treatment of the underlying malignancy. Hospices offer the appropriate palliative environment for such patients as well as physical and psychological respite to the carers. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:128 / 131
页数:4
相关论文
共 11 条
[1]   Limbic encephalitis and small cell lung cancer - Clinical and immunological features [J].
Alamowitch, S ;
Graus, F ;
Uchuya, M ;
Rene, R ;
Bescansa, E ;
Delattre, JY .
BRAIN, 1997, 120 :923-928
[2]  
CHER LM, 1995, CANCER-AM CANCER SOC, V75, P1678, DOI 10.1002/1097-0142(19950401)75:7<1678::AID-CNCR2820750719>3.0.CO
[3]  
2-2
[4]   Sedation for refractory symptoms of terminal cancer patients in Taiwan [J].
Chiu, TY ;
Hu, WY ;
Lue, BH ;
Cheng, SY ;
Chen, CY .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2001, 21 (06) :467-472
[5]   Double effect, double bind or double speak? [J].
Gilbert, J ;
Kirkham, S .
PALLIATIVE MEDICINE, 1999, 13 (05) :365-366
[6]   Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients [J].
Gultekin, SH ;
Rosenfeld, MR ;
Voltz, R ;
Eichen, J ;
Posner, JB ;
Dalmau, J .
BRAIN, 2000, 123 :1481-1494
[7]   Limbic encephalitis presenting with topographical disorientation and amnesia [J].
Hirayama, K ;
Taguchi, Y ;
Sato, M ;
Tsukamoto, T .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (01) :110-112
[8]   REVERSIBLE PARANEOPLASTIC LIMBIC ENCEPHALITIS [J].
KANIECKI, R ;
MORRIS, JC .
NEUROLOGY, 1993, 43 (11) :2418-2419
[9]   Delirium resulting from paraneoplastic limbic encephalitis caused by Hodgkin's disease [J].
Kung, S ;
Mueller, PS ;
Geda, YE ;
Krahn, LE .
PSYCHOSOMATICS, 2002, 43 (06) :498-501
[10]   Palliative treatments of last resort: Choosing the least harmful alternative [J].
Quill, TE ;
Lee, BC ;
Nunn, S .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :488-493